Evrofarma (ATH:EVROF) Current Deferred Revenue: €0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Evrofarma Current Deferred Revenue?

Evrofarma ATH:EVROF +0.82% Current Deferred Revenue is €0.00 Mil as of . 20.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Evrofarma's current deferred revenue for the quarter that ended in . 20 was €0.00 Mil.

Evrofarma Current Deferred Revenue Related Terms

Evrofarma Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Evrofarma's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evrofarma Current Deferred Revenue Chart

Evrofarma Annual Data
Trend
Current Deferred Revenue

Evrofarma Quarterly Data
Current Deferred Revenue
What does a Current Deferred Revenue of €0.00 Mil mean?
Evrofarma (ATH:EVROF) has a Current Deferred Revenue of €0.00 Mil as of . 20. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Evrofarma and its competitors.
Is Evrofarma's Current Deferred Revenue too high?
Evrofarma's current Current Deferred Revenue is €0.00 Mil.
How does Evrofarma's Current Deferred Revenue compare to FAMI and VATE?
Evrofarma's Current Deferred Revenue of €0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Consumer Packaged Goods company?
A good Current Deferred Revenue depends on the Consumer Packaged Goods industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Evrofarma and its competitors. Evrofarma's current Current Deferred Revenue is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evrofarma stock overvalued right now?
Evrofarma (ATH:EVROF) has a current Current Deferred Revenue of €0.00 Mil. The current Current Deferred Revenue is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Evrofarma (ATH:EVROF), the current Current Deferred Revenue is €0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evrofarma Business Description

Address 1st km Didimoticho-Orestiada, Didimoticho, GRC, 68300
Evrofarma SA through its subsidiary Campus SA produces milk and dairy products such as yogurt and cheese. The company also trades animal feed and animals such as cows, goats and sheep. Its products include Yellow Cheese, Anthotiro, Telemes, Cow's yogurt, Goat's cheese and Feta DPO.